Aldeyra Therapeutics Inc (ALDX): Next-Year EPS Estimate 48.97%
As of 2026-06-04, Aldeyra Therapeutics Inc (ALDX) has a next-year EPS growth estimate of 48.97%.
ALDX was first flagged by our screen on 2026-05-27, when analyst consensus for its next-year EPS growth was revised from 44.11% to 48.97%. Current-year growth is projected at 27.68%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 48.97%
- EPS growth this year
- 27.68%
- EPS next quarter (est)
- -$0.10
- Last price
- $1.76
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 48.97% | 27.68% | -$0.10 | $1.76 |
| 2026-06-03 | 48.97% | 27.68% | -$0.10 | $1.86 |
| 2026-06-02 | 48.97% | 27.68% | -$0.10 | $1.64 |
| 2026-06-01 | 48.97% | 27.68% | -$0.10 | $1.66 |
| 2026-05-31 | 48.97% | 27.68% | -$0.10 | $1.75 |
| 2026-05-28 | 48.97% | 27.68% | -$0.05 | $1.75 |
| 2026-05-27 | 48.97% | 27.68% | -$0.05 | $1.71 |
| 2026-05-26 | 44.11% | 25.45% | -$0.07 | $1.78 |
| 2026-05-25 | 44.11% | 25.45% | -$0.07 | $1.55 |
| 2026-05-24 | 44.11% | 25.45% | -$0.07 | $1.55 |
| 2026-05-21 | 44.11% | 25.45% | -$0.07 | $1.59 |
| 2026-05-20 | 44.11% | 25.45% | -$0.07 | $1.55 |
| 2026-05-19 | 44.11% | 25.45% | -$0.07 | $1.54 |
| 2026-05-18 | 44.11% | 25.45% | -$0.07 | $1.60 |
| 2026-05-17 | 44.11% | 25.45% | -$0.07 | $1.68 |
| 2026-05-14 | 44.11% | 25.45% | -$0.07 | $1.66 |
| 2026-05-13 | 44.11% | 25.45% | -$0.07 | $1.67 |
| 2026-05-12 | 44.11% | 25.45% | -$0.07 | $1.71 |
| 2026-05-11 | 36.23% | 17.86% | -$0.08 | $1.76 |
| 2026-05-10 | 32.97% | 17.41% | -$0.10 | $1.73 |
| 2026-05-07 | 32.97% | 17.41% | -$0.10 | $1.73 |
| 2026-05-06 | 32.97% | 17.41% | -$0.10 | $1.74 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Aldeyra Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Aldeyra Therapeutics Inc (ALDX) has a next-year EPS growth estimate of 48.97%, based on analyst consensus.
When was the latest EPS estimate revision for ALDX?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 44.11% to 48.97%.
What sector and industry does Aldeyra Therapeutics Inc belong to?▾
Aldeyra Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALDX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aldeyra Therapeutics Inc (ALDX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports